Wellington Management Group LLP Abb Vie Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Abb Vie Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 1,567,155 shares of ABBV stock, worth $275 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,567,155

Previous 2,882,581 45.63%

Holding current value

$275 Million

Previous $494 Million 37.41%

% of portfolio

0.06%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $216 Million - $262 Million	-1,315,426 Reduced 45.63%	1,567,155 $309 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $5.8 Million - $6.78 Million	37,498 Added 1.32%	2,882,581 $494 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $455 Million - $518 Million	2,845,083 New	2,845,083 $518 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $131 Million - $148 Million	954,374 New	954,374 $148 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $11.8 Million - $13.6 Million	88,172 Added 26.76%	417,644 $62.3 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $68,905 - $85,748	-520 Reduced 0.16%	329,472 $44.4 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $5.72 Million - $6.59 Million	39,559 Added 13.62%	329,992 $52.6 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $3.02 Million - $3.62 Million	-21,814 Reduced 6.99%	290,433 $47 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2.25 Million - $2.58 Million	-16,790 Reduced 5.1%	312,247 $41.9 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $7.69 Million - $9.77 Million	55,853 Added 20.45%	329,037 $50.4 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $930,722 - $1.15 Million	-7,052 Reduced 2.52%	273,184 $44.3 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $1.98 Million - $2.5 Million	18,416 Added 7.03%	280,236 $37.9 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $2.28 Million - $2.59 Million	-21,431 Reduced 7.57%	261,820 $28.2 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $8.37 Million - $9.33 Million	79,592 Added 39.08%	283,251 $31.9 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $2.66 Million - $2.93 Million	-26,017 Reduced 11.33%	203,659 $22 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $3.64 Million - $4.92 Million	-45,230 Reduced 16.45%	229,676 $24.6 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $5.75 Million - $6.75 Million	66,904 Added 32.17%	274,906 $24.1 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $2 Million - $2.67 Million	-27,220 Reduced 11.57%	208,002 $20.4 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $37,603 - $57,011	583 Added 0.25%	235,222 $17.9 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $16.9 Million - $21.2 Million	234,639 New	234,639 $20.8 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Abb Vie Inc. Transaction History